Facility Marks Largest Translational Research Center Dedicated to Brain Tumor Drug Development and Treatment Worldwide
Category Archives: AZBio News
HTG Forms New Drug Discovery Business Unit
New unit to focus on development of drug candidates through use of HTG Transcriptome PanelContinue reading
Digital Health Technologies Hold Key to New Parkinson’s Treatments
Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson’s therapies.Continue reading
Opportunity Alert: Flinn Foundation Translational Research Seed Grants Program
The Flinn Foundation will fund up to 10 research teams focused on advancing new products or services to address a compelling clinical need during the next round of its Translational Research Seed Grants Program.Continue reading
TGen Looks Beyond COVID-19 as it Advances Pathogen Sequencing
Genomic analysis of SARS-CoV-2, aided by seqWell’s technology, increases sequencing output by 10-fold
Lilly and Banner Alzheimer’s Institute collaborate on planned Phase 3 prevention trial of donanemab
Trial will include participants at risk for cognitive and functional decline related to Alzheimer’s disease Continue reading
Launch of UNITE4TB Partnership Marks a New Era in Tuberculosis Treatment Development
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development ConsortiumContinue reading
Like priming a pump, changes in cells damaged by chronic lung disease can result in severe COVID
Results from a TGen-led international study suggest that SARS-CoV-2 takes advantage of genetic changes among patients with pre-existing lung diseasesContinue reading
FDA clears the CATS®-D Disposable Tonometer Prism.
The FDA has cleared the CATS®-D Disposable Tonometer Prism for sale in the United States, assuring that eye care clinicians have accurate intraocular pressure (IOP) measurement data — a key metric — for the diagnosis and treatment of glaucoma and other serious ocular conditions.
The patented CATS®-D Tonometer Prism is designed to deliver improved IOP measurement accuracy with a sterile, disposable tip replacement for the Goldmann tonometer.
TGen study suggests a variety of factors beyond age influence reaction time
Reaction time helps measure healthy vs. diseased brains, revealing potential connections tied to the risk of Alzheimer’s disease and dementiaContinue reading